A Stanford study found estrogen-only menopausal hormone therapy linked to 35% lower Alzheimer's pathology and 39% lower dementia odds in women.

Women on regimens of estrogen-only menopausal hormone therapy are at reduced risk of Alzheimer's disease, a study by Stanford Medicine investigators has found. Because estrogen-only therapy is generally ...